Compare LACTOSE INDIA with DINESH ALLOR - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LACTOSE INDIA vs HEMO ORGANIC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LACTOSE INDIA HEMO ORGANIC LACTOSE INDIA/
HEMO ORGANIC
 
P/E (TTM) x -84.6 -41.4 - View Chart
P/BV x 1.3 23.3 5.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 LACTOSE INDIA   HEMO ORGANIC
EQUITY SHARE DATA
    LACTOSE INDIA
Mar-21
HEMO ORGANIC
Mar-20
LACTOSE INDIA/
HEMO ORGANIC
5-Yr Chart
Click to enlarge
High Rs4217 241.3%   
Low Rs1612 137.9%   
Sales per share (Unadj.) Rs30.60.8 3,828.5%  
Earnings per share (Unadj.) Rs-2.2-0.1 3,416.5%  
Cash flow per share (Unadj.) Rs1.6-0.1 -2,593.4%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs30.10.3 9,175.5%  
Shares outstanding (eoy) m11.443.47 329.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.918.1 5.2%   
Avg P/E ratio x-13.3-230.3 5.8%  
P/CF ratio (eoy) x17.6-230.3 -7.6%  
Price / Book Value ratio x1.044.0 2.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m33050 659.4%   
No. of employees `000NANA-   
Total wages/salary Rs m1060 75,957.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3503 12,622.0%  
Other income Rs m30-   
Total revenues Rs m3533 12,735.0%   
Gross profit Rs m620 -32,752.6%  
Depreciation Rs m440-   
Interest Rs m540 181,600.0%   
Profit before tax Rs m-330 14,863.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-80-   
Profit after tax Rs m-250 11,263.6%  
Gross profit margin %17.8-6.9 -259.7%  
Effective tax rate %24.20-   
Net profit margin %-7.1-7.9 89.9%  
BALANCE SHEET DATA
Current assets Rs m1971 18,764.8%   
Current liabilities Rs m1161 8,874.8%   
Net working cap to sales %23.1-9.7 -238.2%  
Current ratio x1.70.8 211.4%  
Inventory Days Days590-  
Debtors Days Days67190 741.7%  
Net fixed assets Rs m6860 3,432,050.0%   
Share capital Rs m11435 330.0%   
"Free" reserves Rs m230-34 -687.6%   
Net worth Rs m3451 30,250.0%   
Long term debt Rs m3930 1,963,250.0%   
Total assets Rs m8831 82,564.5%  
Interest coverage x0.4-6.3 -6.3%   
Debt to equity ratio x1.10 6,490.1%  
Sales to assets ratio x0.42.6 15.3%   
Return on assets %3.4-17.7 -19.0%  
Return on equity %-7.2-19.1 37.5%  
Return on capital %3.0-16.4 -18.0%  
Exports to sales %00-   
Imports to sales %7.40-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m26NA-   
Fx inflow Rs m250-   
Fx outflow Rs m270-   
Net fx Rs m-20-   
CASH FLOW
From Operations Rs m220 36,083.3%  
From Investments Rs m-62NA-  
From Financial Activity Rs m45NA-  
Net Cashflow Rs m50 8,533.3%  

Share Holding

Indian Promoters % 49.1 16.9 291.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.7 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 50.9 83.2 61.2%  
Shareholders   15,737 1,432 1,099.0%  
Pledged promoter(s) holding % 47.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LACTOSE INDIA With:   SUN PHARMA  SAKAR HEALTHCARE   LINCOLN PHAR  VIVIMED LABS  AMRUTANJAN HEALTHCARE  



Today's Market

India's Fiscal Deficit, Anand Rathi Wealth IPO, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a negative note yesterday. Benchmark indices edged lower as global cues turned bearish after US pharma.

Related Views on News

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

How to Find Your Next 10-Bagger in this Market(Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LACTOSE INDIA SHARE PRICE


Nov 30, 2021 (Close)

TRACK LACTOSE INDIA

  • Track your investment in LACTOSE INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LACTOSE INDIA - CIPLA COMPARISON

COMPARE LACTOSE INDIA WITH

MARKET STATS